Skip to content

Arrowhead Research ARWR Prepaid & Other Current

Prepaid & Other Current at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$306.08M+37.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$62.91M+77.9%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$64.96M+179%
Royalty Pharma logo
Royalty PharmaRPRX
$10.16M+230%
AbbVie logo
AbbVieABBV
$150M-97.3%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's prepaid & other current?
Arrowhead Research (ARWR) reported prepaid & other current of $21.72M in Q1 2026.
How has Arrowhead Research's prepaid & other current changed year-over-year?
Arrowhead Research's prepaid & other current decreased by 8.6% year-over-year, from $23.77M to $21.72M.
What is the long-term trend for Arrowhead Research's prepaid & other current?
Over 5 years (2020 to 2025), Arrowhead Research's prepaid & other current has grown at a 20.8% compound annual growth rate (CAGR), from $4.25M to $10.93M.
What does prepaid & other current mean?
Payments made for future services or other assets expected to be used within a year.
How do you interpret prepaid & other current?
Significant fluctuations may indicate changes in the scale of upcoming research projects or shifts in vendor payment terms.
How does prepaid & other current compare across companies?
Generally a small percentage of total assets for biotech companies, though it can spike during periods of heavy clinical trial preparation.